PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $279,385 | +16.5% | 196,750 | -5.7% | 0.00% | – |
Q2 2023 | $239,890 | +38.4% | 208,600 | +27.6% | 0.00% | – |
Q1 2023 | $173,310 | -31.1% | 163,500 | -1.2% | 0.00% | – |
Q4 2022 | $251,560 | -25.6% | 165,500 | +3.8% | 0.00% | – |
Q3 2022 | $338,000 | +87.8% | 159,500 | +19.0% | 0.00% | – |
Q2 2022 | $180,000 | -28.9% | 134,000 | +11.9% | 0.00% | – |
Q1 2022 | $253,000 | -42.9% | 119,800 | +0.3% | 0.00% | – |
Q4 2021 | $443,000 | -25.7% | 119,500 | 0.0% | 0.00% | – |
Q3 2021 | $596,000 | -23.5% | 119,500 | 0.0% | 0.00% | – |
Q2 2021 | $779,000 | +40.9% | 119,500 | +48.8% | 0.00% | – |
Q1 2021 | $553,000 | -42.1% | 80,300 | -14.2% | 0.00% | – |
Q4 2020 | $955,000 | +132.9% | 93,600 | -20.0% | 0.00% | – |
Q3 2020 | $410,000 | -40.8% | 117,000 | -15.6% | 0.00% | – |
Q2 2020 | $692,000 | +82.6% | 138,700 | +24.3% | 0.00% | – |
Q1 2020 | $379,000 | – | 111,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |